{"id":"W2766175045","doi":"10.1002/cncr.31082","title":"Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy","year":2017,"lang":"en","type":"article","venue":"Cancer","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ariad Pharmaceuticals; Pfizer","keywords":"Medicine; Cohort; Internal medicine; Bosutinib; Quality of life (healthcare); Myeloid leukemia; Cancer; Visual analogue scale; Oncology; Nilotinib; Imatinib; Physical therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001823981,0.0004956913,0.001240741,0.0001584221,0.0003108603,0.00011052,0.0005804287,0.0001604008,0.0003800265],"category_scores_gemma":[0.000198082,0.0003617734,0.00005464234,0.0001884491,0.0001631029,0.0003887798,0.0004844086,0.0003015097,0.000005590557],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004443926,"about_ca_system_score_gemma":0.001662807,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01037391,"about_ca_topic_score_gemma":0.01041959,"domain_scores_codex":[0.9967126,0.0001284329,0.001052359,0.001020142,0.0005743834,0.0005120864],"domain_scores_gemma":[0.996861,0.0001334406,0.0007514515,0.001645473,0.0002411903,0.0003674349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01921086,0.00447183,0.8151472,0.00006028272,0.0009640522,0.0004074544,0.01031959,0.00001556582,0.003842574,0.000001337613,0.00005469136,0.1455045],"study_design_scores_gemma":[0.07163502,0.007852282,0.9162958,0.0008511252,0.0002125645,0.000003923818,0.0002412896,0.00004040758,0.002361977,0.000002647035,0.0001492029,0.0003537108],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926196,0.0007132107,0.000001973812,0.00041423,0.0003062699,0.005538919,0.0002655836,0.00003445877,0.0001057749],"genre_scores_gemma":[0.9982443,0.0005524043,0.00008321176,0.0003357892,0.0001009862,0.0003285278,0.0001416403,0.00008068351,0.0001324737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1451508,"threshold_uncertainty_score":0.9998834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05714009683101398,"score_gpt":0.3696422830219721,"score_spread":0.312502186190958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}